COMPANY

Timberlyne Therapeutics

Keywords: immunology autoimmune diseases antibody monoclonal antibody

Profile checked Oct 10, 2026

Timeline

Jan 10, 2025 Raise Private equity round — Series A: $180M (total, as published), announced Jan 10, 2025. Source: company's own press page. source ↗

Raised: $180.0M. Last 2 years.

Jan 10, 2025 Private equity round — Series A: $180M (total, as published), announced Jan 10, 2025. Source: company's own press page. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of Bain Capital Life Sciences (captured Oct 12, 2026). portfolio page ↗